| CRS | Chronic rhinosinusitis |
| eCRS | Eosinophilic chronic rhinosinusitis |
| Non-eCRS | Non-eosinophilic chronic rhinosinusitis |
| CRSwNP | Chronic rhinosinusitis with nasal polyps |
| CRSsNP | Chronic rhinosinusitis without nasal polyps |
| MBP | Major basic protein |
| ECP | Eosinophil cationic protein |
| EPX | Eosinophil peroxidase |
| EDN | Eosinophil-derived neurotoxin |
| EDGP | Eosinophil-derived granule protein |
| RNase 2 | Ribonuclease 2 (EDN) |
| RNase 3 | Ribonuclease 3 (ECP) |
| MPO | Myeloperoxidase |
| IgE | Immunoglobulin E |
| IL | Interleukin |
| IFN-γ | Interferon-gamma |
| TNF-α | Tumor necrosis factor-alpha |
| AERD | Aspirin-exacerbated respiratory disease |
| ASA | Aspirin sensitivity |
| CCAD | Central compartment atopic disease |
| AFRS | Allergic fungal rhinosinusitis |
| JESREC | Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis |
| ESS | Endoscopic sinus surgery |
| FESS | Functional endoscopic sinus surgery |
| SNOT-22 | 22-item Sino-Nasal Outcome Test |
| SNOT-20 | 20-item Sino-Nasal Outcome Test |
| VAS | Visual analogue scale |
| TNSS | Total nasal symptom score |
| NPS | Nasal Polyp Score |
| CT | Computed tomography |
| hpf | High-power field |
| IHC | Immunohistochemistry |
| ELISA | Enzyme-linked immunosorbent assay |
| qRT-PCR | Quantitative reverse transcription polymerase chain reaction |
| AUC | Area under the curve |
| OR | Odds ratio |
| HR | Hazard ratio |
| CI | Confidence interval |
| NPV | Negative predictive value |
| PPV | Positive predictive value |
| LTE4 | Leukotriene E4 |
| PGD2 | Prostaglandin D2 |
| 15(S)-HETE | 15(S)-hydroxyeicosatetraenoic acid |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROSPERO | International Prospective Register of Systematic Reviews |
| NOS | Newcastle-Ottawa Scale |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| RCT | Randomized controlled trial |